Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1CNS 1

Conditions

Neuroblastoma 15Central Nervous System Neoplasms 12Testicular Neoplasms 9Testicular Germ Cell Tumor 8Teratoma 6Sarcoma 6Ovarian Neoplasms 6Carcinoma, Renal Cell 5Seminoma 4Neuroectodermal Tumors, Primitive, Peripheral 4Medulloblastoma 4Endodermal Sinus Tumor 4Astrocytoma 4Wilms Tumor 3Rhabdoid Tumor 3Retinoblastoma 3Osteosarcoma 3Optic Nerve Glioma 3Neoplasms 3Kidney Neoplasms 3Carcinoma, Embryonal 3Brain Neoplasms 3Spinal Cord Neoplasms 2Rhabdomyosarcoma 2Liver Neoplasms 2Hepatoblastoma 2Familial ependymoma 2Chondrosarcoma 2Uveal Melanoma 1Urinary Bladder Neoplasms 1

Interventions

Paclitaxel 2pegfilgrastim 1Taxes 1Lapatinib 1Ifosfamide 1Cisplatin 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Dysgerminoma × Ifosfamide × CNS × Clear all
NCT00470366 2017-11-28

Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
60 enrolled 11 charts
CNSGenitourinaryGynecologic

Testicular Germ Cell Tumor, Dysgerminoma, Ovarian Neoplasms, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Carcinoma, Embryonal, Seminoma, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡